You can be aware of the latest KPC and other carbapenemases news on a daily basis. Every day there are up to 10-15 KPC news stories. We sort them, weed out the duplicates and then create two things. A free daily newsletter, and our Twitter feed. Save yourself hours and be informed in ways that will practically help you, whether you are a patient or a health care worker. See the latest news below and scroll down for a guide to where we get it from and why you can trust it.
- Fighting Antibiotic Resistance, One Prescription at a Time - North Carolina Health News
- Genetic identification and antimicrobial susceptibility of clinically isolated anaerobic bacteria: A prospective multicenter surveillance study in Japan.
- Whole genome sequencing, molecular typing and in vivo virulence of OXA-48-producing Escherichia coli isolates including ST131 H30-Rx, H22 and H41 sub... - PubMed - NCBI
- A Triple Disk Enrichment Method for CRE Screening. - PubMed - NCBI
- Molecular Characterization of Klebsiella pneumoniae Clinical Isolates with Elevated Resistance to Carbapenems. - PubMed - NCBI
- Eliminating Duodenoscope-Associated Transmission of Carbapenem-Resistant Enterobacteriaceae (CRE): In Search of an Optimal Strategy. - PubMed - NCBI
- Should we treat patients with only one set of positive blood cultures for extensively drug-resistant Acinetobacter baumannii the same as multiple s... - PubMed - NCBI
- Stalking a lethal superbug by whole-genome sequencing and phylogenetics: Influence on unraveling a major hospital outbreak of carbapenem-resistant ... - PubMed - NCBI
- [Analysis of characteristics of bacteria in respiratory tract infection in 2013-2016 in Heibei 3A hospital: a single-center report of 7 497 patients]. - PubMed - NCBI
- Hospital design and innovative cleaning can protect patients from resistant bacteria
- Carbapenemase Detection among Carbapenem-Resistant Glucose-Nonfermenting Gram-Negative Bacilli
- Efficacy of High-Dose Meropenem (Six Grams per Day) in Treatment of Experimental Murine Pneumonia Induced by Meropenem-Resistant Pseudomonas aeruginosa.
- Detection of the IncX3 plasmid carrying blaKPC-3 in a Serratia marcescens strain isolated from a kidney-liver transplanted patient.
- New Polymyxin B Dosing Strategies To Fortify Old Allies in the War against KPC-2-Producing Klebsiella pneumoniae.
- The effect of antibiotic use on prevalence of nosocomial vancomycin-resistant enterococci- an ecologic study.
- High-Dose Ampicillin-Sulbactam Combinations Combat Polymyxin-Resistant Acinetobacter baumannii in a Hollow-Fiber Infection Model.
- [Comparison of phenotypic methods and polymerase chain reaction for the detection of carbapenemase production in clinical Klebsiella pneumoniae isolates].
- Carbapenemase VCC-1-Producing Vibrio cholerae in Coastal Waters of Germany.
- Co-production of NDM-1 and OXA-232 by ST16 Klebsiella pneumoniae, Italy, 2016.
- Multidrug-Resistant Sequence Type 235 Pseudomonas aeruginosa Clinical Isolates Producing IMP-26 with Increased Carbapenem-Hydrolyzing Activities in Vietnam.
Visit our specialist pages for further KPC insights
- KPC News – Daily Updates
- How is the KPC superbug treated
- What are KPC superbug symptoms
- What is Klebsiella Pneumonia?
- What is the KPC superbug?
KPC News – Medical Journals
We monitor medical journals for the latest research on issues surrounding KPC and CRE. We pay particular attention to items about transmission, treatment, key drugs and infection control. With over 1000 relevant journal articles being released every year, our service can help you see the latest research headlines at a glance.
KPC News – Twitter
We discover cutting edge analysis via the Twitter accounts of leading infection control specialists, medical journalists and national and international agencies. These unique voices are at the heart of the science surrounding KPC and CRE and the discussions about key trends and best practice.
KPC – Mainstream media
Newspapers all over the world carry KPC and CRE related news. We monitor this using news alert software and add key stories to our news feed as well as removing the many duplicates of the same story that sometimes appear. The media shape popular perceptions of the extent and impact of KPC and CRE. Our KPC news service helps you discover, in 2 minutes a day, the important stories that you might want to explore further.
The newsletter and Twitter feed we offer are unique. We believe they will be helpful to infection control specialists, general nursing staff, patient advocates, medical equipment manufacturers and those working on KPC related drug projects. They are both free. Sponsors for the newsletter are welcome – you can find more information by emailing dave(at)tahilla.com